Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
services for beneficiaries with end-stage renal disease (ESRD) that are paid under the ESRD prospective payment system
No signal, less pain
Research-use warnings are shown on the vial label and site policy pages
All injections are administered by licensed professionals using medical-grade, sterile ingredients
Additionally, the target achievement percentage for the QCC was 126.92%, and the improvement percentage was 40.47%
If you decide to use your insurance for your visit and the claim is fully processed, the clinic may not be able to revert to a self-pay rate, depending on insurance carrier and plan
US$ 26.56
US$ 29.81
US$ 27.90
US$ 23.85
